| Title | Anti-Obesity Drug Discovery and Development |
| Type of Publication | Book series |
| Discipline | Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4) |
| Impact Score | 0.00 |
| SCImago Journal Rank (SJR) | 0.131 |
| h-index | 1 |
| Overall Rank | 23239 |
| Publisher Name | Bentham Science Publishers |
| Publication Country | United Arab Emirates |
| International Standard Serial Number (ISSN) | 22102698, 24679615 |
| Coverage and History | 2020-2021 |
| Best Quartile | Q4 |
| Total Citations Received (Last 3 Year) |
0 |
Anti-Obesity Drug Discovery and Development is a book series published by Bentham Science Publishers. This book series covers the area[s] related to Drug Discovery, Pharmaceutical Science, Pharmacology (medical), etc.
The coverage history of this book series is as follows: 2020-2021.
The rank of this book series is 23239. This book series's impact score, h-index, and SJR are 0.00, 1, and 0.131, respectively. The ISSN of this book series is/are as follows: 22102698, 24679615.
The best quartile of Anti-Obesity Drug Discovery and Development is Q4.
This book series has received a total of 0 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Anti-Obesity Drug Discovery and Development is 0.00. It is computed in the year 2023 as per its definition and based on Scopus data.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.00 |
| 2021 | 0.50 |
The h-index of Anti-Obesity Drug Discovery and Development is 1. By definition of the h-index, this book series has at least 1 published articles with more than 1 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Anti-Obesity Drug Discovery and Development is/are as follows: 22102698, 24679615.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Anti-Obesity Drug Discovery and Development is ranked 23239 among 27955 Journals, Conferences, and Book Series.
As per SJR, this book series is ranked 0.131.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Anti-Obesity Drug Discovery and Development is Bentham Science Publishers. The publishing house of this book series is located in the United Arab Emirates. Its coverage history is as follows: 2020-2021.
Please check the official website of this book series to find out the complete details and Call For Papers (CFPs).
If your area of research or discipline is related to Drug Discovery, Pharmaceutical Science, Pharmacology (medical), etc., please check the book series's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Anti-Obesity Drug Discovery and Development is 0.00. It is computed in the year 2023.
The latest h-index of Anti-Obesity Drug Discovery and Development is 1. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Anti-Obesity Drug Discovery and Development is 0.131. It is calculated in the year 2023.
The latest ranking of Anti-Obesity Drug Discovery and Development is 23239. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Anti-Obesity Drug Discovery and Development is published by Bentham Science Publishers. The publication country of this book series is United Arab Emirates.
This standard abbreviation of Anti-Obesity Drug Discovery and Development is .
Anti-Obesity Drug Discovery and Development is a book series published by Bentham Science Publishers.
The scope of Anti-Obesity Drug Discovery and Development is as follows:
For detailed scope of Anti-Obesity Drug Discovery and Development, check the official website of this book series.
The International Standard Serial Number (ISSN) of Anti-Obesity Drug Discovery and Development is/are as follows: 22102698, 24679615.
The best quartile for Anti-Obesity Drug Discovery and Development is Q4.
The coverage history of Anti-Obesity Drug Discovery and Development is as follows 2020-2021.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | Journal | Thieme Medical Publishers Inc. | 16018 | 37 | 0.65 | |
| European Union Politics | Journal | SAGE Publications Ltd | 2250 | 72 | 2.64 | |
| Journal of International Financial Management and Accounting | Journal | Wiley-Blackwell Publishing Ltd | 6179 | 42 | 6.09 | |
| Journal, Indian Academy of Clinical Medicine | Journal | Indian Academy of Clinical Medicine | 24608 | 16 | 0.06 | |
| Journal of Education and Work | Journal | Brill Academic Publishers | 9268 | 43 | 1.93 | |
| Modern Language Journal | Journal | Wiley-Blackwell | 918 | 103 | 3.89 | |
| British Journal of Special Education | Journal | Wiley-Blackwell Publishing Ltd | 12024 | 42 | 1.24 | |
| Archives of the Balkan Medical Union | Journal | Balkan medical union | 23243 | 10 | 0.24 | |
| Journal des Professionnels de l'Enfance | Journal | TPMA | 27577 | 2 | 0.00 | |
| Transactions on Embedded Computing Systems | Journal | Association for Computing Machinery (ACM) | 6019 | 61 | 2.25 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 0.00 |
| 2021 | 0.50 |
0.00
0.131
1
23239
